FIELD: pharmaceutics.
SUBSTANCE: invention relates to the treatment of WHIM syndrome. A method for the treatment or prevention of WHIM syndrome in a human, who needs it, includes the injection to the specified human of CXCR4 antagonist in the amount effective for the treatment or prevention of WHIM syndrome. According to the invention, CXCR4 antagonist is N-[4-(11-sulfoxo-1,4,7-triazacyclotetradecanil)-1,4-phenylenbis(methylene)]-2-(aminomethyl)pyridine 
or its pharmaceutically acceptable salt or metal complex.
EFFECT: invention provides for expanding the arsenal of means of a specific purpose.
9 cl, 2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF CXCR4 ANTAGONISTS | 2012 |
|
RU2638802C2 |
| METHODS FOR ACTIVATION OF CELLS-PRECURSORS/STEM CELLS | 2002 |
|
RU2309741C2 |
| CYCLIC POLYAMINE CONTAINING NITROGEN ATOMS N IN RING PROTECTED BY PRINCIPLE "ALL EXCEPT ONE (N-1)" AND METHODS FOR THEIR PREPARING | 2001 |
|
RU2311413C2 |
| INTEGRATED STRESS PATHWAY PRODRUG MODULATORS | 2019 |
|
RU2824500C2 |
| COMPOUNDS SUITABLE FOR THERAPY AGAINST HIV | 2019 |
|
RU2806030C2 |
| LUMINESCENT MATERIAL USING (Y, Gd)-CONTAINING NANOPARTICLES AND SURFACE-BOUND ORGANIC LIGANDS | 2007 |
|
RU2434925C2 |
| DOUBLE NEUROKININ-1/NEUROKININ-3 RECEPTOR ANTAGONISTS FOR TREATING SEX HORMONE DEPENDENT DISEASES | 2016 |
|
RU2743206C2 |
| BIS(THIO-HYDRAZIDE AMIDE) COMPOSITION | 2006 |
|
RU2433822C2 |
| COMPOUNDS OF SUBSTITUTED DIAZEPANES AS ANTAGONISTS OF OREXIN RECEPTORS | 2007 |
|
RU2561727C2 |
| [4-(5-AMINOMETHYL-2-FLOUROPHENYL)-PYPERIDIN-1-YL]-(7- FLUORO-1-(2-METHOXYETHYL)-4-TRIFLUOROMETHOXY-1H-INDOL-3-YL]-METHANONE AS MAST CELL TRYPTASE INHIBITOR | 2009 |
|
RU2509766C2 |
